Site updated at Wednesday, 22 June 2016

Living with Dementia


Merck becomes bigger Alzheimer’s player, with new trial

Merck & Co Inc has moved to the forefront of Alzheimer’s disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein associated with the memory-robbing disease.

The drugmaker said on Monday it had started the trial to evaluate… Merck becomes bigger Alzheimer’s player, with new trial   

Alzheimer’s Disease

cardiac arrest1 - intracoronary ultrasound1 - alzheimer's plan1 - american psychiatric association3 - tau tangles1 - exposure to ddt1 - cell biology1 - α-synuclein protein2 - aerobic exercise1 - mind diet1 - neurotransmitter1 - cvd1 - anterograde amnesia10 - pet1 - neurodegenerative conditions1 - risperidone2 - brain cell damage2 - heart disease8 - risk factors1 - gum disease1 - parkinson's disease59 - wernicke's syndrome10 - beta-amyloid protein1 - psychotic symptoms1 - amylin1 - signs of alzheimers1 - hip fracture1 - dopamine-deficient worms1 - degenerative neurological disorder1 - treatment of alzheimer's1 -